Annual Working Capital
-$244.00 M
-$482.00 M-202.52%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual working capital is -$244.00 million, with the most recent change of -$482.00 million (-202.52%) on December 31, 2024.
- During the last 3 years, TEVA annual working capital has fallen by -$1.79 billion (-115.78%).
- TEVA annual working capital is now -104.52% below its all-time high of $5.39 billion, reached on December 31, 2015.
Performance
TEVA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$244.00 M
+$1.24 B+83.55%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly working capital is -$244.00 million, with the most recent change of +$1.24 billion (+83.55%) on December 31, 2024.
- Over the past year, TEVA quarterly working capital has increased by +$1.25 billion (+83.68%).
- TEVA quarterly working capital is now -103.90% below its all-time high of $6.26 billion, reached on June 30, 2010.
Performance
TEVA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TEVA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -202.5% | +83.7% |
| 3 y3 years | -115.8% | -120.9% |
| 5 y5 years | -16.2% | -53.5% |
TEVA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -115.8% | at low | -115.8% | +83.7% |
| 5 y | 5-year | -115.8% | at low | -115.8% | +83.7% |
| alltime | all time | -104.5% | +90.4% | -103.9% | +90.4% |
Teva Pharmaceutical Industries Limited Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$244.00 M(-202.5%) | -$244.00 M(-83.5%) |
| Sep 2024 | - | -$1.48 B(+5.6%) |
| Jun 2024 | - | -$1.41 B(-6.0%) |
| Mar 2024 | - | -$1.50 B(-728.2%) |
| Dec 2023 | $238.00 M(-59.1%) | $238.00 M(+667.7%) |
| Sep 2023 | - | $31.00 M(-87.3%) |
| Jun 2023 | - | $245.00 M(-77.5%) |
| Mar 2023 | - | $1.09 B(+87.3%) |
| Dec 2022 | $582.00 M(-62.4%) | $582.00 M(-818.5%) |
| Sep 2022 | - | -$81.00 M(-106.9%) |
| Jun 2022 | - | $1.17 B(+39.4%) |
| Mar 2022 | - | $838.00 M(-45.8%) |
| Dec 2021 | $1.55 B(-1072.3%) | $1.55 B(+369.9%) |
| Sep 2021 | - | $329.00 M(+151.1%) |
| Jun 2021 | - | $131.00 M(-58.0%) |
| Mar 2021 | - | $312.00 M(-296.2%) |
| Dec 2020 | -$159.00 M(-24.3%) | -$159.00 M(-378.9%) |
| Sep 2020 | - | $57.00 M(-94.5%) |
| Jun 2020 | - | $1.03 B(+83.3%) |
| Mar 2020 | - | $562.00 M(-367.6%) |
| Dec 2019 | -$210.00 M(-60.2%) | -$210.00 M(-86.6%) |
| Sep 2019 | - | -$1.56 B(+141.9%) |
| Jun 2019 | - | -$647.00 M(+8.4%) |
| Mar 2019 | - | -$597.00 M(+13.1%) |
| Dec 2018 | -$528.00 M(-79.2%) | -$528.00 M(-44.4%) |
| Sep 2018 | - | -$949.00 M(-291.3%) |
| Jun 2018 | - | $496.00 M(-818.8%) |
| Mar 2018 | - | -$69.00 M(-97.3%) |
| Dec 2017 | -$2.54 B(+101.5%) | -$2.54 B(+254.1%) |
| Sep 2017 | - | -$717.00 M(-16.8%) |
| Jun 2017 | - | -$862.00 M(-19.3%) |
| Mar 2017 | - | -$1.07 B(-15.2%) |
| Dec 2016 | -$1.26 B(-123.4%) | -$1.26 B(-33.7%) |
| Sep 2016 | - | -$1.90 B(-148.3%) |
| Jun 2016 | - | $3.93 B(-3.8%) |
| Mar 2016 | - | $4.09 B(-24.2%) |
| Dec 2015 | $5.39 B(+156.0%) | $5.39 B(-1228.2%) |
| Sep 2015 | - | -$478.00 M(-59.3%) |
| Jun 2015 | - | -$1.17 B(-136.2%) |
| Mar 2015 | - | $3.24 B(+54.0%) |
| Dec 2014 | $2.11 B(+20.1%) | $2.11 B(-6.5%) |
| Sep 2014 | - | $2.25 B(+33.2%) |
| Jun 2014 | - | $1.69 B(-17.3%) |
| Mar 2014 | - | $2.05 B(+16.6%) |
| Dec 2013 | $1.75 B(-49.4%) | $1.75 B(+0.5%) |
| Sep 2013 | - | $1.75 B(+39.0%) |
| Jun 2013 | - | $1.26 B(-39.0%) |
| Mar 2013 | - | $2.06 B(-40.6%) |
| Dec 2012 | $3.47 B(+346.2%) | $3.47 B(-20.4%) |
| Sep 2012 | - | $4.36 B(+3.3%) |
| Jun 2012 | - | $4.22 B(+214.9%) |
| Mar 2012 | - | $1.34 B(+72.5%) |
| Dec 2011 | $777.00 M(-66.9%) | $777.00 M(-49.5%) |
| Sep 2011 | - | $1.54 B(-39.7%) |
| Jun 2011 | - | $2.55 B(-19.4%) |
| Mar 2011 | - | $3.17 B(+34.9%) |
| Dec 2010 | $2.35 B(-48.3%) | $2.35 B(-7.4%) |
| Sep 2010 | - | $2.54 B(-59.5%) |
| Jun 2010 | - | $6.26 B(+46.7%) |
| Mar 2010 | - | $4.27 B(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $4.54 B(+54.1%) | $4.54 B(+7.4%) |
| Sep 2009 | - | $4.22 B(+11.3%) |
| Jun 2009 | - | $3.79 B(+47.7%) |
| Mar 2009 | - | $2.57 B(-12.7%) |
| Dec 2008 | $2.94 B(-34.4%) | $2.94 B(-50.7%) |
| Sep 2008 | - | $5.97 B(+11.2%) |
| Jun 2008 | - | $5.37 B(+13.2%) |
| Mar 2008 | - | $4.74 B(+5.6%) |
| Dec 2007 | $4.49 B(+25.7%) | $4.49 B(+14.7%) |
| Sep 2007 | - | $3.91 B(-0.5%) |
| Jun 2007 | - | $3.94 B(+16.4%) |
| Mar 2007 | - | $3.38 B(-5.3%) |
| Dec 2006 | $3.57 B(+10.0%) | $3.57 B(+8.2%) |
| Sep 2006 | - | $3.30 B(+23.4%) |
| Jun 2006 | - | $2.67 B(+22.6%) |
| Mar 2006 | - | $2.18 B(-32.8%) |
| Dec 2005 | $3.25 B(+62.4%) | $3.25 B(+45.3%) |
| Sep 2005 | - | $2.23 B(+2.7%) |
| Jun 2005 | - | $2.17 B(+5.7%) |
| Mar 2005 | - | $2.06 B(+3.0%) |
| Dec 2004 | $2.00 B(-1.2%) | $2.00 B(-8.7%) |
| Sep 2004 | - | $2.19 B(+24.2%) |
| Jun 2004 | - | $1.76 B(+4.7%) |
| Mar 2004 | - | $1.68 B(-16.7%) |
| Dec 2003 | $2.02 B(+46.8%) | $2.02 B(+79.4%) |
| Sep 2003 | - | $1.13 B(-23.5%) |
| Jun 2003 | - | $1.47 B(+3.2%) |
| Mar 2003 | - | $1.43 B(+3.6%) |
| Dec 2002 | $1.38 B(-4.3%) | $1.38 B(+4.5%) |
| Sep 2002 | - | $1.32 B(+0.1%) |
| Jun 2002 | - | $1.32 B(-2.3%) |
| Mar 2002 | - | $1.35 B(-6.3%) |
| Dec 2001 | $1.44 B(+74.5%) | $1.44 B(+2.3%) |
| Sep 2001 | - | $1.41 B(+55.5%) |
| Jun 2001 | - | $905.41 M(+4.1%) |
| Mar 2001 | - | $870.12 M(+5.5%) |
| Dec 2000 | $825.09 M(+120.9%) | $825.09 M(+75.1%) |
| Sep 2000 | - | $471.21 M(+58.3%) |
| Jun 2000 | - | $297.74 M(-24.8%) |
| Mar 2000 | - | $395.95 M(+6.0%) |
| Dec 1999 | $373.45 M(+56.5%) | $373.45 M(+41.6%) |
| Sep 1999 | - | $263.70 M(-12.8%) |
| Jun 1999 | - | $302.50 M(+14.3%) |
| Mar 1999 | - | $264.60 M(+10.9%) |
| Dec 1998 | $238.60 M(-1.1%) | $238.60 M(+13.2%) |
| Sep 1998 | - | $210.80 M(-13.9%) |
| Jun 1998 | - | $244.80 M(+1.6%) |
| Mar 1998 | - | $240.90 M(-0.1%) |
| Dec 1997 | $241.20 M(+18.1%) | $241.20 M(+18.1%) |
| Dec 1996 | $204.20 M(+88.6%) | $204.20 M(+88.6%) |
| Dec 1995 | $108.30 M(-32.2%) | $108.30 M(-32.2%) |
| Dec 1994 | $159.80 M(+29.3%) | $159.80 M(+29.3%) |
| Dec 1993 | $123.60 M(+32.6%) | $123.60 M(+32.6%) |
| Dec 1992 | $93.20 M(-10.6%) | $93.20 M(-10.6%) |
| Dec 1991 | $104.20 M(+23.9%) | $104.20 M(+23.9%) |
| Dec 1990 | $84.10 M(+9.5%) | $84.10 M(+9.5%) |
| Dec 1989 | $76.80 M(+103.2%) | $76.80 M(+103.2%) |
| Dec 1988 | $37.80 M(-6.4%) | $37.80 M(-6.4%) |
| Mar 1987 | $40.40 M(-4.7%) | $40.40 M(-4.7%) |
| Mar 1986 | $42.40 M | $42.40 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual working capital?
- What is the all time high annual working capital for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual working capital year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly working capital?
- What is the all time high quarterly working capital for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly working capital year-on-year change?
What is Teva Pharmaceutical Industries Limited annual working capital?
The current annual working capital of TEVA is -$244.00 M
What is the all time high annual working capital for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual working capital is $5.39 B
What is Teva Pharmaceutical Industries Limited annual working capital year-on-year change?
Over the past year, TEVA annual working capital has changed by -$482.00 M (-202.52%)
What is Teva Pharmaceutical Industries Limited quarterly working capital?
The current quarterly working capital of TEVA is -$244.00 M
What is the all time high quarterly working capital for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly working capital is $6.26 B
What is Teva Pharmaceutical Industries Limited quarterly working capital year-on-year change?
Over the past year, TEVA quarterly working capital has changed by +$1.25 B (+83.68%)